The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells
By A Mystery Man Writer
Description
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://www.researchgate.net/publication/360321841/figure/fig4/AS:1163081770110981@1654311711304/Hypothetical-model-illustrating-the-multiple-actions-of-SL-145-on-TNBC-tumor-growth-and_Q320.jpg)
PDF) A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://www.researchgate.net/publication/24191455/figure/fig5/AS:310200385982493@1450968943628/Effect-of-trastuzumab-on-tumor-growth-of-HER2-overexpressing-xenotransplants-Tumor.png)
Effect of trastuzumab on tumor growth of HER2-overexpressing
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://www.mdpi.com/biomolecules/biomolecules-12-00884/article_deploy/html/images/biomolecules-12-00884-g009-550.jpg)
Biomolecules, Free Full-Text
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://www.mdpi.com/cancers/cancers-13-04778/article_deploy/html/images/cancers-13-04778-g001.png)
Cancers, Free Full-Text
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12672-016-0251-8/MediaObjects/12672_2016_251_Fig4_HTML.gif)
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://ars.els-cdn.com/content/image/1-s2.0-S0163725823000815-gr1.jpg)
Detailed curriculum vitae of HER2-targeted therapy - ScienceDirect
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://i1.rgstatic.net/publication/360321841_A_novel_HSP90_inhibitor_SL-145_suppresses_metastatic_triple-negative_breast_cancer_without_triggering_the_heat_shock_response/links/627093d43a23744a725ec783/largepreview.png)
PDF) A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41388-022-02206-z/MediaObjects/41388_2022_2206_Fig1_HTML.png)
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://ars.els-cdn.com/content/image/1-s2.0-S0163725823000815-gr4.jpg)
Detailed curriculum vitae of HER2-targeted therapy - ScienceDirect
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://file.medchemexpress.com/product_pic/hy-145102.gif)
NCT-58, HSP90 C-terminal Inhibitor
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41388-022-02269-y/MediaObjects/41388_2022_2269_Fig4_HTML.png)
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://file.medchemexpress.com/product_pic/hy-112626.gif)
HER2-positive MedChemExpress (MCE) Life Science Reagents
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://www.mdpi.com/biomolecules/biomolecules-12-00884/article_deploy/html/images/biomolecules-12-00884-g001-550.jpg)
Biomolecules, Free Full-Text
![The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells](https://www.researchgate.net/publication/375386002/figure/fig2/AS:11431281209815141@1701849680844/DOXA-impairs-metastatic-ability-by-suppressing-JAK-STAT3-signaling-A-Immunoblot-analyses_Q320.jpg)
Soeun Park's research works Korea University, Seoul (KU) and other places
from
per adult (price varies by group size)